Le Lézard
Classified in: Health
Subjects: AWD, LGB, DEI, ESG

Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Seventh Consecutive Year


SECAUCUS, N.J., Dec. 6, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that for the seventh straight year it has received a score of 100% on the Human Rights Campaign Foundation's 2022-2024 Corporate Equality Index (CEI), the nation's foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality.

"We are honored to earn a 100% score on the Corporate Equality Index for the seventh consecutive year," said Cecilia McKenney, Quest's Chief Human Resources Officer and Pride Employee Business Network (EBN) co-sponsor. "As we live our Purpose of working together to create a healthier world, one life at a time, Quest is committed to providing our employees with a diverse, equitable and inclusive workplace where employees feel safe to bring their authentic selves to work. Our diverse workforce empowers the valuable insights we are able to deliver to our patients, providers and communities."

Quest has 10 EBNs, including the Pride EBN, an all-inclusive resource group for LGBTQ+ employees, straight/cis allies, parents and family members of LGBTQ+ individuals. For over 20 years, the Pride EBN has engaged colleagues and senior leaders to promote awareness, education, and advocacy of social justice for the LGBTQ+ community.

Inclusion and Diversity is an integral part of Quest.

"By consistently inviting new perspectives and exploring new experiences, the company strives to create an inclusive, respectful and empathetic workplace where everyone feels they belong," said Desyra Highsmith Holcomb, Quest's Director of Inclusion & Diversity.

An example of the company's commitment to equity is the Quest Inclusion and Diversity (I&D) Council, which advises senior leaders as I&D goals and priorities are established, acts as a visible I&D leader and represents the needs and perspectives of diverse demographics across the company and communities.

The CEI rates companies on detailed criteria under four central pillars: non-discrimination policies across business entities; equitable benefits for LGBTQ+ workers and their families; supporting an inclusive culture; and corporate social responsibility.  Established in 2002, the 2023-2024 Corporate Equality Index is the 21st iteration of the nation's leading benchmarking tool for evaluating a company's LGBTQ+ workplace inclusion policies, serving employees, consumers, and investors. This year's survey engaged over 1,300 businesses.

Read more about Quest's award-winning culture on the company's ESG Resources page.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

SOURCE Quest Diagnostics

SOURCE Quest Diagnostics


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: